Current understanding of Pneumocystis immunology

Related Experiment Video

Updated: Jun 17, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

Michelle N Kelly1, Judd E Shellito

  • 1Section of Pulmonary/Critical Care Medicine, LSU Health Sciences Center, Medical Education Building 3205, 1901 Perdido Street, New Orleans, LA 70112, USA. mkelly3@lsuhsc.edu

Future Microbiology
|December 22, 2009
PubMed

Insights

Pneumocystis pneumonia (PCP) is a serious fungal infection in immunocompromised individuals. Recent research explores host immunity and immunotherapies to combat this persistent public health threat.

Area of Science:

  • Medical Mycology
  • Immunology
  • Infectious Diseases

Background:

  • Pneumocystis jirovecii causes Pneumocystis pneumonia (PCP), a significant opportunistic infection, particularly in HIV-infected individuals.
  • While highly active antiretroviral therapy (HAART) has reduced PCP incidence, increases in non-HIV immunocompromised populations, drug resistance, and HIV cases in developing nations sustain its relevance.
  • PCP remains a critical public health concern, necessitating ongoing research into host immune responses and novel therapeutic strategies.

Purpose of the Study:

  • To review recent research (last 5 years) on the host immune response to Pneumocystis jirovecii.
  • To investigate innate, cell-mediated, and humoral immunity against Pneumocystis.
  • To explore associated immunotherapies developed for Pneumocystis pneumonia (PCP) treatment and prevention.

Main Methods:

  • Literature review focusing on studies published within the last five years.
  • Analysis of research on innate immune mechanisms against Pneumocystis.
  • Examination of studies detailing cell-mediated and humoral immune responses to the pathogen.
  • Review of preclinical and clinical investigations of immunotherapeutic interventions for PCP.

Main Results:

  • Recent studies have elucidated complex innate immune pathways involved in early defense against Pneumocystis.
  • Cell-mediated immunity, particularly T-cell responses, remains crucial for controlling Pneumocystis proliferation.
  • Humoral immunity's role is increasingly recognized, with antibody responses correlating with protection in certain contexts.
  • Several immunotherapy approaches targeting immune enhancement have shown promise in preclinical models.

Conclusions:

  • Understanding the multifaceted host immune response is key to developing effective strategies against Pneumocystis.
  • Immunotherapies represent a promising avenue for preventing and treating Pneumocystis pneumonia, especially in at-risk populations.
  • Continued research is vital to address challenges like drug resistance and emerging cases of Pneumocystis infection.

More Related Videos

A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness12:21

A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness

Published on: September 28, 2022

Visualization of Pseudomonas aeruginosa within the Sputum of Cystic Fibrosis Patients07:25

Visualization of Pseudomonas aeruginosa within the Sputum of Cystic Fibrosis Patients

Published on: July 16, 2020

Related Concept Videos

Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following: